1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Digital RIDTs 1.2.3 Conventional RIDT 1.3 Market by Application 1.3.1 Global Rapid Diagnostic Testing for Influenza Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 POCT 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Rapid Diagnostic Testing for Influenza Market Perspective (2016-2027) 2.2 Rapid Diagnostic Testing for Influenza Growth Trends by Regions 2.2.1 Rapid Diagnostic Testing for Influenza Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Rapid Diagnostic Testing for Influenza Historic Market Share by Regions (2016-2021) 2.2.3 Rapid Diagnostic Testing for Influenza Forecasted Market Size by Regions (2022-2027) 2.3 Rapid Diagnostic Testing for Influenza Industry Dynamic 2.3.1 Rapid Diagnostic Testing for Influenza Market Trends 2.3.2 Rapid Diagnostic Testing for Influenza Market Drivers 2.3.3 Rapid Diagnostic Testing for Influenza Market Challenges 2.3.4 Rapid Diagnostic Testing for Influenza Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Rapid Diagnostic Testing for Influenza Players by Revenue 3.1.1 Global Top Rapid Diagnostic Testing for Influenza Players by Revenue (2016-2021) 3.1.2 Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Players (2016-2021) 3.2 Global Rapid Diagnostic Testing for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Rapid Diagnostic Testing for Influenza Revenue 3.4 Global Rapid Diagnostic Testing for Influenza Market Concentration Ratio 3.4.1 Global Rapid Diagnostic Testing for Influenza Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Rapid Diagnostic Testing for Influenza Revenue in 2020 3.5 Rapid Diagnostic Testing for Influenza Key Players Head office and Area Served 3.6 Key Players Rapid Diagnostic Testing for Influenza Product Solution and Service 3.7 Date of Enter into Rapid Diagnostic Testing for Influenza Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Rapid Diagnostic Testing for Influenza Breakdown Data by Type 4.1 Global Rapid Diagnostic Testing for Influenza Historic Market Size by Type (2016-2021) 4.2 Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Type (2022-2027) 5 Rapid Diagnostic Testing for Influenza Breakdown Data by Application 5.1 Global Rapid Diagnostic Testing for Influenza Historic Market Size by Application (2016-2021) 5.2 Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Rapid Diagnostic Testing for Influenza Market Size (2016-2027) 6.2 North America Rapid Diagnostic Testing for Influenza Market Size by Type 6.2.1 North America Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) 6.2.2 North America Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) 6.2.3 North America Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2027) 6.3 North America Rapid Diagnostic Testing for Influenza Market Size by Application 6.3.1 North America Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) 6.3.2 North America Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) 6.3.3 North America Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2027) 6.4 North America Rapid Diagnostic Testing for Influenza Market Size by Country 6.4.1 North America Rapid Diagnostic Testing for Influenza Market Size by Country (2016-2021) 6.4.2 North America Rapid Diagnostic Testing for Influenza Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Rapid Diagnostic Testing for Influenza Market Size (2016-2027) 7.2 Europe Rapid Diagnostic Testing for Influenza Market Size by Type 7.2.1 Europe Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) 7.2.2 Europe Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) 7.2.3 Europe Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2027) 7.3 Europe Rapid Diagnostic Testing for Influenza Market Size by Application 7.3.1 Europe Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) 7.3.2 Europe Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) 7.3.3 Europe Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2027) 7.4 Europe Rapid Diagnostic Testing for Influenza Market Size by Country 7.4.1 Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2016-2021) 7.4.2 Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size (2016-2027) 8.2 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Type 8.2.1 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2027) 8.3 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Application 8.3.1 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2027) 8.4 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region 8.4.1 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Rapid Diagnostic Testing for Influenza Market Size (2016-2027) 9.2 Latin America Rapid Diagnostic Testing for Influenza Market Size by Type 9.2.1 Latin America Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) 9.2.2 Latin America Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) 9.2.3 Latin America Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2027) 9.3 Latin America Rapid Diagnostic Testing for Influenza Market Size by Application 9.3.1 Latin America Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) 9.3.2 Latin America Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) 9.3.3 Latin America Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2027) 9.4 Latin America Rapid Diagnostic Testing for Influenza Market Size by Country 9.4.1 Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2016-2021) 9.4.2 Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size (2016-2027) 10.2 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type 10.2.1 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2027) 10.3 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application 10.3.1 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2027) 10.4 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country 10.4.1 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 BD 11.1.1 BD Company Details 11.1.2 BD Business Overview 11.1.3 BD Rapid Diagnostic Testing for Influenza Introduction 11.1.4 BD Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.1.5 BD Recent Development 11.2 Abbot (Alere) 11.2.1 Abbot (Alere) Company Details 11.2.2 Abbot (Alere) Business Overview 11.2.3 Abbot (Alere) Rapid Diagnostic Testing for Influenza Introduction 11.2.4 Abbot (Alere) Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.2.5 Abbot (Alere) Recent Development 11.3 Quidel 11.3.1 Quidel Company Details 11.3.2 Quidel Business Overview 11.3.3 Quidel Rapid Diagnostic Testing for Influenza Introduction 11.3.4 Quidel Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.3.5 Quidel Recent Development 11.4 Roche 11.4.1 Roche Company Details 11.4.2 Roche Business Overview 11.4.3 Roche Rapid Diagnostic Testing for Influenza Introduction 11.4.4 Roche Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.4.5 Roche Recent Development 11.5 Thermo Fisher Scientific 11.5.1 Thermo Fisher Scientific Company Details 11.5.2 Thermo Fisher Scientific Business Overview 11.5.3 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Introduction 11.5.4 Thermo Fisher Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.5.5 Thermo Fisher Scientific Recent Development 11.6 Meridian Bioscience 11.6.1 Meridian Bioscience Company Details 11.6.2 Meridian Bioscience Business Overview 11.6.3 Meridian Bioscience Rapid Diagnostic Testing for Influenza Introduction 11.6.4 Meridian Bioscience Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.6.5 Meridian Bioscience Recent Development 11.7 Analytik Jena 11.7.1 Analytik Jena Company Details 11.7.2 Analytik Jena Business Overview 11.7.3 Analytik Jena Rapid Diagnostic Testing for Influenza Introduction 11.7.4 Analytik Jena Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.7.5 Analytik Jena Recent Development 11.8 Princeton BioMeditech Corporation 11.8.1 Princeton BioMeditech Corporation Company Details 11.8.2 Princeton BioMeditech Corporation Business Overview 11.8.3 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Introduction 11.8.4 Princeton BioMeditech Corporation Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.8.5 Princeton BioMeditech Corporation Recent Development 11.9 BioMerieux 11.9.1 BioMerieux Company Details 11.9.2 BioMerieux Business Overview 11.9.3 BioMerieux Rapid Diagnostic Testing for Influenza Introduction 11.9.4 BioMerieux Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.9.5 BioMerieux Recent Development 11.10 Sekisui Diagnostics 11.10.1 Sekisui Diagnostics Company Details 11.10.2 Sekisui Diagnostics Business Overview 11.10.3 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Introduction 11.10.4 Sekisui Diagnostics Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.10.5 Sekisui Diagnostics Recent Development 11.11 Response Biomedical 11.11.1 Response Biomedical Company Details 11.11.2 Response Biomedical Business Overview 11.11.3 Response Biomedical Rapid Diagnostic Testing for Influenza Introduction 11.11.4 Response Biomedical Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.11.5 Response Biomedical Recent Development 11.12 SA Scientific 11.12.1 SA Scientific Company Details 11.12.2 SA Scientific Business Overview 11.12.3 SA Scientific Rapid Diagnostic Testing for Influenza Introduction 11.12.4 SA Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.12.5 SA Scientific Recent Development 11.13 DiaSorin (Focus Diagnostics) 11.13.1 DiaSorin (Focus Diagnostics) Company Details 11.13.2 DiaSorin (Focus Diagnostics) Business Overview 11.13.3 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Introduction 11.13.4 DiaSorin (Focus Diagnostics) Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.13.5 DiaSorin (Focus Diagnostics) Recent Development 11.14 Wondfo 11.14.1 Wondfo Company Details 11.14.2 Wondfo Business Overview 11.14.3 Wondfo Rapid Diagnostic Testing for Influenza Introduction 11.14.4 Wondfo Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.14.5 Wondfo Recent Development 11.15 Beijing Wantai Biological Pharmacy 11.15.1 Beijing Wantai Biological Pharmacy Company Details 11.15.2 Beijing Wantai Biological Pharmacy Business Overview 11.15.3 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Introduction 11.15.4 Beijing Wantai Biological Pharmacy Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.15.5 Beijing Wantai Biological Pharmacy Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Digital RIDTs Table 3. Key Players of Conventional RIDT Table 4. Global Rapid Diagnostic Testing for Influenza Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Rapid Diagnostic Testing for Influenza Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Rapid Diagnostic Testing for Influenza Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Rapid Diagnostic Testing for Influenza Market Share by Regions (2016-2021) Table 8. Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Rapid Diagnostic Testing for Influenza Market Share by Regions (2022-2027) Table 10. Rapid Diagnostic Testing for Influenza Market Trends Table 11. Rapid Diagnostic Testing for Influenza Market Drivers Table 12. Rapid Diagnostic Testing for Influenza Market Challenges Table 13. Rapid Diagnostic Testing for Influenza Market Restraints Table 14. Global Rapid Diagnostic Testing for Influenza Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Rapid Diagnostic Testing for Influenza Market Share by Players (2016-2021) Table 16. Global Top Rapid Diagnostic Testing for Influenza Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rapid Diagnostic Testing for Influenza as of 2020) Table 17. Ranking of Global Top Rapid Diagnostic Testing for Influenza Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Rapid Diagnostic Testing for Influenza Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Rapid Diagnostic Testing for Influenza Product Solution and Service Table 21. Date of Enter into Rapid Diagnostic Testing for Influenza Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) (US$ Million) Table 24. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Type (2016-2021) Table 25. Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Rapid Diagnostic Testing for Influenza Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Application (2016-2021) Table 29. Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) (US$ Million) Table 32. North America Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) (US$ Million) Table 34. North America Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Rapid Diagnostic Testing for Influenza Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Rapid Diagnostic Testing for Influenza Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2022-2027) & (US$ Million) Table 61. BD Company Details Table 62. BD Business Overview Table 63. BD Rapid Diagnostic Testing for Influenza Product Table 64. BD Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) & (US$ Million) Table 65. BD Recent Development Table 66. Abbot (Alere) Company Details Table 67. Abbot (Alere) Business Overview Table 68. Abbot (Alere) Rapid Diagnostic Testing for Influenza Product Table 69. Abbot (Alere) Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) & (US$ Million) Table 70. Abbot (Alere) Recent Development Table 71. Quidel Company Details Table 72. Quidel Business Overview Table 73. Quidel Rapid Diagnostic Testing for Influenza Product Table 74. Quidel Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) & (US$ Million) Table 75. Quidel Recent Development Table 76. Roche Company Details Table 77. Roche Business Overview Table 78. Roche Rapid Diagnostic Testing for Influenza Product Table 79. Roche Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) & (US$ Million) Table 80. Roche Recent Development Table 81. Thermo Fisher Scientific Company Details Table 82. Thermo Fisher Scientific Business Overview Table 83. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product Table 84. Thermo Fisher Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) & (US$ Million) Table 85. Thermo Fisher Scientific Recent Development Table 86. Meridian Bioscience Company Details Table 87. Meridian Bioscience Business Overview Table 88. Meridian Bioscience Rapid Diagnostic Testing for Influenza Product Table 89. Meridian Bioscience Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) & (US$ Million) Table 90. Meridian Bioscience Recent Development Table 91. Analytik Jena Company Details Table 92. Analytik Jena Business Overview Table 93. Analytik Jena Rapid Diagnostic Testing for Influenza Product Table 94. Analytik Jena Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) & (US$ Million) Table 95. Analytik Jena Recent Development Table 96. Princeton BioMeditech Corporation Company Details Table 97. Princeton BioMeditech Corporation Business Overview Table 98. Princeton BioMeditech Corporation Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) & (US$ Million) Table 99. Princeton BioMeditech Corporation Recent Development Table 100. BioMerieux Company Details Table 101. BioMerieux Business Overview Table 102. BioMerieux Rapid Diagnostic Testing for Influenza Product Table 103. BioMerieux Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) & (US$ Million) Table 104. BioMerieux Recent Development Table 105. Sekisui Diagnostics Company Details Table 106. Sekisui Diagnostics Business Overview Table 107. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product Table 108. Sekisui Diagnostics Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) & (US$ Million) Table 109. Sekisui Diagnostics Recent Development Table 110. Response Biomedical Company Details Table 111. Response Biomedical Business Overview Table 112. Response Biomedical Rapid Diagnostic Testing for Influenza Product Table 113. Response Biomedical Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) & (US$ Million) Table 114. Response Biomedical Recent Development Table 115. SA Scientific Company Details Table 116. SA Scientific Business Overview Table 117. SA Scientific Rapid Diagnostic Testing for Influenza Product Table 118. SA Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) & (US$ Million) Table 119. SA Scientific Recent Development Table 120. DiaSorin (Focus Diagnostics) Company Details Table 121. DiaSorin (Focus Diagnostics) Business Overview Table 122. DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Product Table 123. DiaSorin (Focus Diagnostics) Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) & (US$ Million) Table 124. DiaSorin (Focus Diagnostics) Recent Development Table 125. Wondfo Company Details Table 126. Wondfo Business Overview Table 127. Wondfo Rapid Diagnostic Testing for Influenza Product Table 128. Wondfo Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) & (US$ Million) Table 129. Wondfo Recent Development Table 130. Beijing Wantai Biological Pharmacy Company Details Table 131. Beijing Wantai Biological Pharmacy Business Overview Table 132. Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Product Table 133. Beijing Wantai Biological Pharmacy Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) & (US$ Million) Table 134. Beijing Wantai Biological Pharmacy Recent Development Table 135. Research Programs/Design for This Report Table 136. Key Data Information from Secondary Sources Table 137. Key Data Information from Primary Sources List of Figures Figure 1. Global Rapid Diagnostic Testing for Influenza Market Share by Type: 2020 VS 2027 Figure 2. Digital RIDTs Features Figure 3. Conventional RIDT Features Figure 4. Global Rapid Diagnostic Testing for Influenza Market Share by Application: 2020 VS 2027 Figure 5. Hospitals Case Studies Figure 6. POCT Case Studies Figure 7. Others Case Studies Figure 8. Rapid Diagnostic Testing for Influenza Report Years Considered Figure 9. Global Rapid Diagnostic Testing for Influenza Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Rapid Diagnostic Testing for Influenza Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Rapid Diagnostic Testing for Influenza Market Share by Regions: 2020 VS 2027 Figure 12. Global Rapid Diagnostic Testing for Influenza Market Share by Regions (2022-2027) Figure 13. Global Rapid Diagnostic Testing for Influenza Market Share by Players in 2020 Figure 14. Global Top Rapid Diagnostic Testing for Influenza Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rapid Diagnostic Testing for Influenza as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Rapid Diagnostic Testing for Influenza Revenue in 2020 Figure 16. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Type (2016-2021) Figure 17. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Type (2022-2027) Figure 18. North America Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Rapid Diagnostic Testing for Influenza Market Share by Type (2016-2027) Figure 20. North America Rapid Diagnostic Testing for Influenza Market Share by Application (2016-2027) Figure 21. North America Rapid Diagnostic Testing for Influenza Market Share by Country (2016-2027) Figure 22. United States Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Rapid Diagnostic Testing for Influenza Market Share by Type (2016-2027) Figure 26. Europe Rapid Diagnostic Testing for Influenza Market Share by Application (2016-2027) Figure 27. Europe Rapid Diagnostic Testing for Influenza Market Share by Country (2016-2027) Figure 28. Germany Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Share by Type (2016-2027) Figure 36. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Share by Application (2016-2027) Figure 37. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Share by Region (2016-2027) Figure 38. China Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Rapid Diagnostic Testing for Influenza Market Share by Type (2016-2027) Figure 46. Latin America Rapid Diagnostic Testing for Influenza Market Share by Application (2016-2027) Figure 47. Latin America Rapid Diagnostic Testing for Influenza Market Share by Country (2016-2027) Figure 48. Mexico Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Share by Type (2016-2027) Figure 52. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Share by Application (2016-2027) Figure 53. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Share by Country (2016-2027) Figure 54. Turkey Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. BD Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2016-2021) Figure 58. Abbot (Alere) Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2016-2021) Figure 59. Quidel Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2016-2021) Figure 60. Roche Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2016-2021) Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2016-2021) Figure 62. Meridian Bioscience Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2016-2021) Figure 63. Analytik Jena Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2016-2021) Figure 64. Princeton BioMeditech Corporation Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2016-2021) Figure 65. BioMerieux Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2016-2021) Figure 66. Sekisui Diagnostics Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2016-2021) Figure 67. Response Biomedical Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2016-2021) Figure 68. SA Scientific Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2016-2021) Figure 69. DiaSorin (Focus Diagnostics) Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2016-2021) Figure 70. Wondfo Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2016-2021) Figure 71. Beijing Wantai Biological Pharmacy Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2016-2021) Figure 72. Bottom-up and Top-down Approaches for This Report Figure 73. Data Triangulation Figure 74. Key Executives Interviewed

BD Abbot (Alere) Quidel Roche Thermo Fisher Scientific Meridian Bioscience Analytik Jena Princeton BioMeditech Corporation BioMerieux Sekisui Diagnostics Response Biomedical SA Scientific DiaSorin (Focus Diagnostics) Wondfo Beijing Wantai Biological Pharmacy